J&J Vaccine and Blood Clots: A Risk, if It Exists, Is Tiny
The New York Times
Out of an “abundance of caution,” the F.D.A. is advising doctors to pause the Johnson & Johnson vaccine while it investigates extremely rare blood clots.
On Tuesday morning, U.S. federal health regulators recommended a pause in the use of Johnson & Johnson’s Covid-19 vaccine while they investigated six reports of blood clots in women ages 18 to 48. One has died, and a second is hospitalized in critical condition. As of Monday, 6.8 million people in the United States had received the vaccine without any other serious adverse reactions reported. Experts have yet to determine to what extent, if any, the vaccine is responsible for the clots. But the investigation follows actions by European regulators who concluded that a vaccine made by AstraZeneca may also be the cause of a similar, extremely rare clotting disorder.
The findings showed the highest mortality occurred among infants who were Black, lived in Southern states or had fetal birth defects.
As Lanzhou beef noodle soup goes from regional specialty to global attraction, I set out to find the best bowls in New York City.
As of Tuesday, 22 children and two adults had been infected, all of whom were unvaccinated, local officials said.
It’s the most energetic particle of its kind ever discovered, and scientists have no idea where it came from.
This 30-minute recipe for “Marry Me Salmon” feels special but is easy enough for a weeknight.
The internet erupted in controversy over Felisa Wolfe-Simon and colleagues’ claim of a microbe thriving on arsenic. Nearly 15 years later, she’s pursuing new research on the boundaries of life.
Once thought of as a byproduct of collard greens, brothy, complex potlikker takes on new life as a wonderful base for a Japanese staple.
The new research adds to the mysteries of the planet’s deepest interior region.
The billionaire is leading a group of investors in the unsolicited offer, which complicates the start-up’s plan to raise more money.
At cardiology conferences and diabetes meetings, doctors can’t help noticing that thin seems to be very in.
President Trump’s executive order is altering scientific exploration across a broad swath of fields, even beyond government agencies, researchers say.
After helping President Trump get elected, Elon Musk was poised to dominate the country’s A.I. policies. Then Mr. Altman sneaked into the White House.
Shock and grief rippled through the health community as lifelines for care were abruptly severed.